This is a non-core endpoint: only basic statistics are computed.
Mantle cell lymphoma
C3_MANTLE_CELL_LYMPHOMA
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
394 |
4. Check minimum number of eventsNone |
394 |
5. Include endpointsNone |
394 |
6. Filter based on genotype QC (FinnGen only) |
336 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- C
- First used in FinnGen datafreeze
- DF8
Similar endpoints
↥List of similar endpoints to
Mantle cell lymphoma
based on the number of shared cases.
Similar with more cases:
- Mantle cell lymphoma, including Hilmo
- Non-Hodgkin lymphoma, all
- Non-Hodgkin lymphoma, all, including Hilmo
- Primary_lymphoid and hematopoietic malignant neoplasms
- Liquid cancers
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 336 | 77 | 259 |
| Unadjusted period prevalence (%) | 0.10 | 0.03 | 0.12 |
| Median age at first event (years) | 70.94 | 70.32 | 71.12 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 347
- Matched controls
- 3470
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
4503599627370496.0
307.7
310
*
C83.1
ICD-10 Finland
Mantle cell lymphoma
+∞
307.7
344
*
XW000
NOMESCO Finland
Bone marrow biopsy
109.8
307.7
197
41
WW500
NOMESCO Finland
Blood transfusion
91.7
287.4
157
31
A03FA01
ATC
metoclopramide; systemic, rectal
34.4
260.3
227
181
A04AA01
ATC
ondansetron; systemic, rectal
74.6
223.9
125
26
JN4BD
NOMESCO Finland
Extensive body CT
34.8
223.4
164
87
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
3267.3
193.8
169
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
186.9
162
*
L03AA02
ATC
filgrastim; parenteral
2715.6
173.2
153
*
M04AA01
ATC
allopurinol; systemic
18.2
172.0
237
367
L03AA13
ATC
pegfilgrastim; parenteral
2274.5
154.3
138
*
JN4AD
NOMESCO Finland
Body CT examination
19.6
151.1
141
117
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
23.3
148.6
122
79
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
41.0
130.1
82
26
9673/3-C42.1
ICD-O-3
Mantle cell lymphoma of bone marrow
+∞
122.3
110
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
794.1
118.6
110
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
36.7
112.7
73
25
ZX120
NOMESCO Finland
Intravenous
15.7
108.4
108
97
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
+∞
106.9
97
*
JN6AD
NOMESCO Finland
CT of torso and neck
196.9
99.1
99
7
A49.9
ICD-10 Finland
Bacterial infection, unspecified
9.8
95.7
150
249
H02AB02
ATC
dexamethasone; systemic
162.7
93.5
95
8
A04AA02
ATC
granisetron; systemic, transdermal
+∞
90.7
83
*
WW300
NOMESCO Finland
Transfer of autologic stem cells
+∞
82.7
76
*
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
25.2
80.5
59
28
Z51.5
ICD-10 Finland
Palliative care
13.0
78.2
84
83
D70.82
ICD-10 Finland
Drug-induced neutropenia
470.3
78.1
75
*
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
11.6
75.8
89
100
R59.1
ICD-10 Finland
Generalized enlarged lymph nodes
140.8
74.4
77
7
R50.9
ICD-10 Finland
Fever, unspecified
7.7
74.1
141
282
9673/3-C77.9
ICD-O-3
Mantle cell lymphoma of lymph node, NOS
+∞
72.5
67
*
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
22.7
70.8
54
28
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
66.9
62
*
WZC00
NOMESCO Finland
Treatment plan or consultation
6.4
66.3
188
544
XX3DW
NOMESCO Finland
Time consuming IT work
12.8
64.2
68
65
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
59.1
55
*
1XC02, ,
NOMESCO Finland
236.0
59.0
59
*
PJA10
NOMESCO Finland
Exploration of lymph nodes
226.4
56.9
57
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
56.9
53
*
H02AB06
ATC
prednisolone; systemic
6.5
54.9
268
1184
WF049
NOMESCO Finland
Radiotherapy of metastasis
606.1
54.1
52
*
9673/3-C77.8
ICD-O-3
Mantle cell lymphoma of lymph nodes of multiple regions
+∞
52.4
49
*
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
51.3
48
*
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
12.6
50.7
53
49
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
90.7
49.6
54
7
TGC00
NOMESCO Finland
Bronchial lavation
13.1
49.3
50
44
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
14.1
48.8
47
38
C61
ICD-10 Finland
Malignant neoplasm of prostate
538.2
48.6
47
*
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
524.9
47.5
46
*
390
Kela drug reimbursment
Ibrutinib
+∞
47.0
44
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
+∞
45.9
43
*
212
Kela drug reimbursment
Gout
12.2
45.4
48
45
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
44.8
42
*
J05AB11
ATC
valaciclovir; oral
5.6
44.5
107
256
N02AA05
ATC
oxycodone; systemic
4.9
40.7
118
328
ZX112
NOMESCO Finland
Subcutaneous
73.5
40.2
45
7
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
+∞
39.3
37
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
39.3
37
*
WZC30
NOMESCO Finland
Teaching
5.2
39.1
100
250
1512
Kela drug reimbursment
Ibrutinib
+∞
38.2
36
*
J01MA12
ATC
levofloxacin; systemic
4.4
37.4
130
413
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
7.1
37.2
62
103
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
9.4
36.9
47
57
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
75.0
35.8
40
6
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
87.7
35.6
39
5
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
200.1
35.5
36
*
WF002
NOMESCO Finland
Radical radiotherapy
137.6
35.4
37
*
WW409
NOMESCO Finland
Other aferesis
+∞
35.0
33
*
L01EL01
ATC
ibrutinib; oral
+∞
33.9
32
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
4.8
32.5
88
228
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
31.8
30
*
C85.1
ICD-10 Finland
B-cell lymphoma, unspecified
+∞
30.7
29
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.9
30.4
244
1319
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
117.1
30.2
32
*
UGC12
NOMESCO Finland
Flexible bronchoscopy
5.5
29.4
64
137
116
Kela drug reimbursment
Prostate cancer
+∞
27.5
26
*
WW402
NOMESCO Finland
Leucoferesis
+∞
27.5
26
*
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
+∞
27.5
26
*
PJD45
NOMESCO Finland
Excision of inguinal lymph nodes
292.5
27.1
27
*
C83.9
ICD-10 Finland
Non-follicular (diffuse) lymphoma, unspecified
+∞
26.4
25
*
R59.9
ICD-10 Finland
Enlarged lymph nodes, unspecified
42.3
25.3
31
8
GD1AD
NOMESCO Finland
Thorax CT examination
5.6
25.3
52
105
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
140.1
25.0
26
*
EP1AE
NOMESCO Finland
Neck ultrasound examination
7.6
24.7
37
54
ZX108
NOMESCO Finland
Inhalation
52.5
24.7
29
6
A02BC02
ATC
pantoprazole; systemic
4.0
24.1
285
1846
J18.9
ICD-10 Finland
Pneumonia, unspecified
3.1
23.9
165
780
R06AE07
ATC
cetirizine; oral
3.1
23.6
164
777
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
4.3
23.1
68
185
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
28.2
23.1
31
12
9673/3-C09.9
ICD-O-3
Mantle cell lymphoma of tonsil, NOS
+∞
22.1
21
*
YNB10
NOMESCO Finland
Collection of stem cells for transplant
+∞
22.1
21
*
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.2
21.6
116
470
D64.9
ICD-10 Finland
Anaemia, unspecified
3.6
21.2
83
276
L02AE02
ATC
leuprorelin; implant, parenteral
+∞
21.0
20
*
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
+∞
21.0
20
*
WW200
NOMESCO Finland
Immunization
8.4
20.7
28
36
L01AA02
ATC
chlorambucil; oral
+∞
20.0
19
*
B01AB10
ATC
tinzaparin; parenteral
4.3
19.5
56
149
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
200.4
18.7
19
*
D70.89
ICD-10 Finland
Neutropenic splenomegaly
55.7
18.2
21
*
J17.3*B59
ICD-10 Finland
Pneumonia due to Pneumocystis carinii
70.4
17.9
20
*
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
+∞
17.9
17
*
L01XE27
ATC
[U] ibrutinib
+∞
17.9
17
*
EMA10
NOMESCO Finland
Biopsy of tonsil
+∞
17.9
17
*
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
4.3
17.5
50
132
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
44.6
17.5
21
5
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
+∞
16.8
16
*
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
178.2
16.6
17
*
U07.1
ICD-10 Finland
Emergency use of U07.1 | COVID-19, virus identified
3.1
15.9
77
289
C81.1
ICD-10 Finland
Nodular sclerosis classical Hodgkin lymphoma
+∞
15.7
15
*
L02BB03
ATC
bicalutamide; oral
+∞
15.7
15
*
1AA09, ,
NOMESCO Finland
+∞
15.7
15
*
130
Kela drug reimbursment
Malignant tumour
+∞
15.7
15
*
D69.5
ICD-10 Finland
Secondary thrombocytopenia
+∞
15.7
15
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
15.7
15
*
J01MA14
ATC
moxifloxacin; systemic
3.7
15.7
54
163
H02AB07
ATC
prednisone; oral
3.2
15.6
73
268
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
4.5
15.4
40
98
ZX090
NOMESCO Finland
Other technic of radiotherapy
83.7
14.7
16
*
C82.1
ICD-10 Finland
Follicular lymphoma grade II
+∞
14.7
14
*
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
+∞
14.7
14
*
YNB00
NOMESCO Finland
Excision of bone marrow for transplantation
+∞
14.7
14
*
WX110
NOMESCO Finland
Infiltration anesthesia
2.6
14.5
251
1735
TDM10
NOMESCO Finland
Puncture of maxillary antrum
5.8
14.2
27
50
ZXE00
NOMESCO Finland
One hour or less
2.4
14.1
153
856
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
+∞
13.6
13
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
13.6
13
*
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
4.0
13.3
40
109
R22.1
ICD-10 Finland
Localized swelling, mass and lump, neck
5.7
13.0
25
47
JN3AD
NOMESCO Finland
Abdominal CT examination
3.1
12.9
59
212
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
72.6
12.7
14
*
PJD42
NOMESCO Finland
Excision of axillary lymph nodes
72.6
12.7
14
*
XW4XT
NOMESCO Finland
Biopsy of other inner organ with radiological guidance guidance
+∞
12.6
12
*
C83.00
ICD-10 Finland
Lymphocytic lymphoma
+∞
12.6
12
*
Y77
ICPC
Malignant neoplasm prostate
134.7
12.5
13
*
JN4CD
NOMESCO Finland
Very extensive body CT
10.2
11.9
23
24
B02.9
ICD-10 Finland
Zoster without complication
3.4
11.7
45
145
NEA10
NOMESCO Finland
Exploration of soft tissue of pelvis, percutaneous
67.3
11.7
13
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
11.5
11
*
Z52.89
ICD-10 Finland
Donor of other organ or tissue
+∞
11.5
11
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
11.5
11
*
D72.8
ICD-10 Finland
Other specified disorders of white blood cells
20.9
11.2
16
8
WZB00
NOMESCO Finland
Telephone prescription or other care instructions
2.4
11.2
100
505
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
2.1
10.6
180
1170
L57.0
ICD-10 Finland
Actinic keratosis
3.1
10.6
48
171
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
113.3
10.5
11
*
C81.9
ICD-10 Finland
Hodgkin lymphoma, unspecified
113.3
10.5
11
*
B72
ICPC
Hodgkin Lymphoma
+∞
10.5
10
*
A79
ICPC
Malignancy NOS
+∞
10.5
10
*
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
10.5
10
*
XX9CD
NOMESCO Finland
Very extensive complementary CT
+∞
10.5
10
*
J01DB01
ATC
cefalexin; oral
2.6
10.3
287
2261
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
4.0
10.0
29
77
TPX10
NOMESCO Finland
Implantation of vascular injection port
8.5
10.0
21
26
B01AB05
ATC
enoxaparin; parenteral
2.2
9.9
118
666
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
20.8
9.9
14
7
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.8
9.8
54
215
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.1
9.7
123
712
N05CF01
ATC
zopiclone; oral
2.1
9.6
129
762
EN1AD
NOMESCO Finland
CT examination of mouth and soft tissues of neck
18.2
9.5
14
8
D10.4
ICD-10 Finland
Benign neoplasm: Tonsil
102.7
9.5
10
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
9.4
9
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
9.4
9
*
WF029
NOMESCO Finland
Radiotherapy of local residive tumor
+∞
9.4
9
*
L04.0
ICD-10 Finland
Acute lymphadenitis of face, head and neck
+∞
9.4
9
*
9673/3-C80.9
ICD-O-3
Mantle cell lymphoma of unknown primary site
+∞
9.4
9
*
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
+∞
9.4
9
*
C81.3
ICD-10 Finland
Lymphocyte depleted classical Hodgkin lymphoma
+∞
9.4
9
*
EMB10
NOMESCO Finland
Tonsillectomy
8.1
9.3
20
26
UJF32
NOMESCO Finland
Coloscopy
2.2
9.2
103
566
J01MA02
ATC
ciprofloxacin; systemic
2.0
9.1
151
958
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.2
9.1
98
529
R05
ICD-10 Finland
Cough
2.3
9.1
82
412
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
7.1
9.0
21
31
D47.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue, unspecified
51.3
8.7
10
*
XGX32
NOMESCO Finland
Bronchoscopic ultrasonography
51.3
8.7
10
*
ED1AA
NOMESCO Finland
Mandibular X-ray examination
51.3
8.7
10
*
WX408
NOMESCO Finland
General anesthesy, balanced
2.2
8.6
90
479
A41.8
ICD-10 Finland
Other specified sepsis
7.0
8.5
20
30
TPJ00
NOMESCO Finland
Biopsy of superficial lymph node
92.2
8.5
9
*
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
+∞
8.4
8
*
Z51.0
ICD-10 Finland
Radiotherapy session
+∞
8.4
8
*
L01BC06
ATC
capecitabine; oral
+∞
8.4
8
*
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
+∞
8.4
8
*
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
4.4
8.3
21
50
KE1AT
NOMESCO Finland
Biopsy of prostata with ultrasoudnguidance
4.4
8.3
21
50
C03CA01
ATC
furosemide; systemic
2.0
8.3
149
965
J35.1
ICD-10 Finland
Hypertrophy of tonsils
17.7
8.1
12
7
JN5JR
NOMESCO Finland
Extensive PET-CT of upper body metabolism (eyebrows to thighs)
34.2
8.1
10
*
TPH04
NOMESCO Finland
Cathetrisation of vein
2.1
8.1
89
482
Z2221
NOMESCO Finland
Medical doctor
2.1
8.1
92
505
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
11.2
7.9
14
13
A07AA02
ATC
nystatin; oral
3.4
7.9
29
91
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
9.7
7.9
15
16
J01.0
ICD-10 Finland
Acute maxillary sinusitis
2.3
7.7
69
344
DM1AI
NOMESCO Finland
Cone beam CT of paranasal sinus
8.3
7.7
16
20
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
6.4
7.7
19
31
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
9.2
7.6
15
17
J12.8
ICD-10 Finland
Other viral pneumonia
25.6
7.6
10
*
HA1AA
NOMESCO Finland
X-ray mammography
7.4
7.6
17
24
ZXC50
NOMESCO Finland
Cryotherapy
6.7
7.5
18
28
R4110
NOMESCO Finland
Physiotherapy
2.0
7.5
98
565
R16.1
ICD-10 Finland
Splenomegaly, not elsewhere classified
81.8
7.4
8
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
81.8
7.4
8
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.0
7.4
113
688
J05AB01
ATC
aciclovir; systemic
2.1
7.4
77
408
WD315
NOMESCO Finland
Multiple therapy of methastized malignancy with biomodifiers
+∞
7.3
7
*
OAA41
NOMESCO Finland
Health check based on individual needs
+∞
7.3
7
*
KE3AT
NOMESCO Finland
Transrectal gold marker implantation in prostate under ultrasound guidance
+∞
7.3
7
*
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
7.3
7
*
WB401
NOMESCO Finland
Simple antibody therapy of primary tumour
+∞
7.3
7
*
1CX01, ,
NOMESCO Finland
+∞
7.3
7
*
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
7.3
7
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
7.3
7
*
QBA25
NOMESCO Finland
Destruction of lesion of skin of trunk
30.7
7.2
9
*
SPAT1153
SPAT
Removal of sutures
1.9
7.2
117
727
A41.9
ICD-10 Finland
Sepsis, unspecified
3.6
7.1
24
71
Z3231
NOMESCO Finland
Registered nurse
2.0
6.8
94
551
N02BE01
ATC
paracetamol; systemic, rectal
2.4
6.7
306
2624
WZC10
NOMESCO Finland
Written specialist consultation based on a referral from a dentist or a physician
3.9
6.7
20
54
R22.0
ICD-10 Finland
Localized swelling, mass and lump, head
5.7
6.7
18
33
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
12.6
6.6
11
9
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.8
6.6
34
130
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
7.1
6.6
15
22
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.7
6.5
37
149
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.9
6.5
109
680
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
3.1
6.5
28
97
R50.8
ICD-10 Finland
Other specified fever
18.4
6.3
9
5
9673/3-C77.4
ICD-O-3
Mantle cell lymphoma of lymph nodes of inguinal region or leg
+∞
6.3
6
*
9591/3-C77.9
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of lymph node, NOS
+∞
6.3
6
*
9673/3-C77.0
ICD-O-3
Mantle cell lymphoma of lymph nodes of head, face and neck
+∞
6.3
6
*
A04AD12
ATC
aprepitant; systemic
+∞
6.3
6
*
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
+∞
6.3
6
*
C83.39
ICD-10 Finland
Diffuse non-Hodgkin's large cell lymphoma UNS
+∞
6.3
6
*
C83.80
ICD-10 Finland
B-cell lymphoma in marginal zone
+∞
6.3
6
*
8070/3-C44.9
ICD-O-3
Squamous cell carcinoma, NOS, of skin, NOS
+∞
6.3
6
*
YX9AW, ,
NOMESCO Finland
+∞
6.3
6
*
D80.8
ICD-10 Finland
Other immunodeficiencies with predominantly antibody defects
+∞
6.3
6
*
B74
ICPC
Malignant neoplasm blood other
+∞
6.3
6
*
9673/3-C77.3
ICD-O-3
Mantle cell lymphoma of lymph nodes of axilla or arm
+∞
6.3
6
*
115
Kela drug reimbursment
Breast cancer
+∞
6.3
6
*
9673/3-C16.9
ICD-O-3
Mantle cell lymphoma of stomach, NOS
+∞
6.3
6
*
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
+∞
6.3
6
*
FM1FN
NOMESCO Finland
Heart function isotope examination
+∞
6.3
6
*
NK6AN
NOMESCO Finland
Total body bone isotope imaging
27.2
6.3
8
*
UDH02
NOMESCO Finland
Rhinopharyngoscopy
3.0
6.2
28
100
U09.9
ICD-10 Finland
Post COVID-19 condition, unspecified
12.8
6.1
10
8
127
Kela drug reimbursment
Transplant complication
10.3
6.1
11
11
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
147
34
74.28
259.36
2.1
1.2
—
—
—
0
0
111
42
38.39
168.45
3.7
5.5
460.36
179.43
iu/ml
—
11
7
152
186
13.76
125.88
4.9
1.8
8.57
11.51
g/l
6.35
145
175
72
24
37.59
112.08
1.7
1.4
—
—
—
0
0
95
70
18.31
106.63
2.3
1.3
—
—
—
0
0
95
71
18.05
105.79
2.3
1.2
—
—
—
0
0
77
43
22.73
98.68
2.5
1.3
—
—
—
0
0
64
34
22.85
83.39
1.3
1.2
146.52
171.42
au/ml
0.67
27
13
50
13
44.77
82.64
4.3
1.8
0.36
0.79
e9/l
1.45
45
13
70
60
14.36
70.97
1.7
1.2
—
—
—
0
0
72
7
129.28
68.90
2.8
2.7
—
—
—
0
0
72
68
13.10
68.64
1.8
1.2
—
—
—
0
0
145
329
6.85
66.43
3.7
1.9
62.96
63.88
e9/l
0.11
115
246
54
34
18.63
64.60
1.7
1.4
—
—
—
0
0
53
33
18.78
63.73
1.7
1.2
—
—
—
0
0
186
558
6.03
62.26
3.1
1.8
—
—
—
0
0
43
20
24.40
58.65
2.9
1.5
—
—
—
0
0
44
22
22.76
58.28
2.9
1.5
—
—
—
0
0
282
1275
7.47
57.13
10.7
3.9
34.04
35.15
g/l
2.72
274
1178
301
1462
8.99
55.76
40.2
5.8
3.21
4.50
e9/l
27.09
281
1263
56
49
13.44
55.64
1.7
1.2
—
—
—
0
0
60
60
11.88
54.67
1.8
1.2
—
—
—
0
0
104
211
6.61
52.24
2.3
1.5
—
—
—
0
0
143
400
5.38
50.21
2.5
1.8
—
—
—
0
0
148
427
5.30
50.06
2.5
1.7
—
—
—
0
0
37
19
21.68
48.24
1.2
1.2
—
—
—
0
0
37
20
20.59
47.16
3.1
1.2
—
—
—
0
0
37
20
20.59
47.16
3.1
1.2
—
—
—
0
0
37
20
20.59
47.16
3.1
1.2
—
—
—
0
0
58
73
9.34
44.42
1.8
1.6
—
—
—
0
0
71
114
7.57
44.26
2.5
3.5
—
—
—
0
0
36
22
18.14
43.27
5.1
2.5
45.89
58.29
%
1.31
36
17
213
921
4.40
40.69
10.1
2.1
2.34
2.34
mmol/l
0.08
204
794
278
1487
5.37
39.16
14.1
6.4
1.21
1.20
mmol/l
0.53
242
1274
41
39
11.79
38.25
1.4
1.0
358.75
286.11
u/ml
0.25
16
19
41
45
10.20
34.58
3.2
1.4
33.46
33.20
pg
0.12
41
45
35
5
77.44
31.51
4.1
1.4
1.56
1.80
%
—
35
5
43
60
8.04
29.95
1.6
1.4
—
—
—
0
0
145
596
3.46
27.32
7.4
2.1
2.45
2.43
mmol/l
1.60
139
518
221
1210
3.28
25.13
6.5
2.6
—
—
estimate
—
0
0
92
295
3.88
25.09
7.8
2.2
4.80
8.57
umol/l
4.52
84
261
123
480
3.42
24.83
2.3
1.3
1.91
3.00
g/l
7.28
101
279
60
144
4.83
23.94
3.1
1.4
2.98
2.85
ug/l
0.09
49
110
306
2095
4.90
23.55
30.1
5.7
81.23
78.45
u/l
0.72
301
1932
27
6
48.62
22.71
1.3
1.0
—
—
—
0
0
184
972
2.90
21.13
4.1
3.1
21.41
142.97
e6/l
1.01
147
743
44
90
5.45
21.02
2.0
1.3
—
—
—
0
0
166
844
2.85
20.28
3.9
3.0
0.23
0.42
e6/l
1.37
132
618
26
32
8.70
19.89
1.3
1.3
—
—
—
0
0
38
72
5.80
19.67
1.6
1.4
—
—
—
0
0
271
1819
3.24
19.07
5.8
4.4
2.25
677.58
e6/l
—
8
31
293
2075
3.65
18.49
8.1
4.3
16.01
12.70
mm/h
2.54
282
1892
137
663
2.76
17.95
6.7
2.3
—
—
—
0
0
139
687
2.71
17.36
3.0
2.3
4.41
3.84
e6/l
0.11
128
620
93
372
3.05
17.27
4.9
3.2
1.72
1.89
mmol/l
0.18
83
315
27
19
15.30
16.61
1.9
1.2
—
—
—
0
0
29
25
12.55
16.37
1.9
1.2
—
—
—
0
0
24
14
18.30
15.85
2.0
1.3
—
—
—
0
0
24
15
17.08
15.47
2.0
1.3
—
—
—
0
0
22
11
21.25
15.30
4.1
1.2
—
—
—
0
0
22
11
21.25
15.30
4.1
1.2
—
—
—
0
0
22
11
21.25
15.30
4.1
1.2
—
—
—
0
0
22
11
21.25
15.30
4.1
1.2
—
—
—
0
0
21
9
24.72
15.29
4.2
1.1
—
—
—
0
0
21
9
24.72
15.29
4.2
1.2
—
—
—
0
0
21
9
24.72
15.29
4.2
1.1
—
—
—
0
0
27
25
11.61
14.77
1.1
1.0
—
—
—
0
0
60
208
3.28
14.01
2.5
1.5
—
—
—
0
0
40
108
4.06
13.51
1.6
1.2
0.36
0.29
g/l
0.08
33
96
52
170
3.42
13.31
1.7
1.5
—
—
—
0
0
226
1525
2.38
13.17
16.1
17.8
1.24
1.36
inr
2.84
193
1274
19
11
18.17
12.66
1.5
1.0
—
—
—
0
0
22
19
12.28
12.50
1.1
1.2
—
—
—
0
0
30
69
4.66
12.42
2.7
1.2
—
—
—
0
0
49
163
3.34
12.17
1.6
1.6
1.63
1.54
g/l
0.22
40
145
35
93
4.07
12.06
1.3
1.2
3.33
1.41
ratio
0.98
12
59
98
482
2.44
11.66
3.6
3.0
0.90
1.61
e6/l
0.81
49
241
103
519
2.40
11.61
3.7
2.9
1.03
0.99
e6/l
0.05
55
280
198
1312
2.19
11.39
3.2
2.3
—
—
—
0
0
62
251
2.79
10.92
4.4
3.6
4.95
5.21
kpa
1.91
62
242
36
105
3.71
10.89
1.3
1.2
66.49
52.30
mg/l
0.47
29
91
36
105
3.71
10.89
1.3
1.2
36.88
40.03
mg/l
0.16
27
92
96
483
2.37
10.76
2.6
2.5
2.08
2.22
g/l
1.81
90
446
55
212
2.89
10.60
4.6
3.8
2.47
2.39
mmol/l
0.06
50
155
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
35
105
3.60
10.16
3.0
2.3
0.42
0.37
iu/ml
0.27
22
58
14
7
20.76
9.88
3.2
1.4
—
—
—
0
0
14
7
20.76
9.88
3.2
1.4
—
—
—
0
0
15
10
15.61
9.60
3.1
1.4
—
—
—
0
0
15
10
15.61
9.60
3.1
1.4
—
—
—
0
0
180
1201
2.04
9.59
3.4
2.9
452.66
158.03
ug/l
7.01
165
1101
208
1462
2.06
9.58
4.2
3.8
0.00
0.00
estimate
-0.00
63
302
27
72
3.98
9.25
1.4
1.2
—
—
—
0
0
27
72
3.98
9.25
1.4
1.2
—
—
—
0
0
136
830
2.05
9.18
2.1
2.2
2.93
2.73
mg/l
0.52
117
700
68
317
2.42
8.91
5.9
3.1
—
—
—
0
0
16
15
11.12
8.88
1.2
1.1
—
—
—
0
0
209
1500
1.99
8.75
4.3
3.8
0.00
0.02
estimate
0.65
61
286
207
1487
1.97
8.57
4.2
3.8
0.00
0.00
estimate
-0.00
63
307
12
6
20.64
8.52
2.9
1.3
23.08
28.75
u/l
—
12
6
170
1144
1.95
8.52
3.5
3.4
1338.69
1711.05
ng/l
0.89
156
986
23
63
3.84
7.59
1.3
1.4
—
—
—
0
0
17
25
7.09
7.38
3.4
1.2
—
—
—
0
0
17
26
6.82
7.20
3.4
1.2
—
—
—
0
0
17
26
6.82
7.20
3.4
1.2
—
—
—
0
0
140
924
1.86
7.11
2.7
2.4
54.06
64.13
u/l
1.12
135
852
13
13
10.34
7.09
1.6
1.8
—
—
—
0
0
13
13
10.34
7.09
1.6
1.8
—
—
—
0
0
34
126
2.88
7.00
4.8
1.5
—
—
—
0
0
17
28
6.33
6.86
3.4
1.2
—
—
—
0
0
17
28
6.33
6.86
3.4
1.2
—
—
—
0
0
17
28
6.33
6.86
3.4
1.2
—
—
—
0
0
18
32
5.87
6.86
3.6
2.5
—
—
—
0
0
51
235
2.37
6.79
2.8
2.1
36.92
36.77
u/l
0.01
37
190
10
6
17.11
6.78
1.2
1.3
—
—
—
0
0
28
96
3.08
6.59
1.4
1.3
—
—
—
0
0
6
0
+∞
6.27
1.7
0.0
—
—
—
0
0
107
675
1.85
6.11
3.3
4.2
147.11
399.90
ng/l
1.80
95
579
308
2680
2.33
6.01
57.2
15.6
23.81
27.47
mg/l
1.77
301
2177
98
607
1.86
5.90
2.2
1.7
1.80
1.41
mg/l
0.39
88
473
10
9
11.40
5.83
1.8
2.6
1181.80
791.67
u/ml
—
10
9
10
9
11.40
5.83
1.0
1.3
—
—
—
0
0
74
424
1.95
5.62
9.8
6.9
1.07
1.10
mmol/l
0.02
61
347
124
837
1.75
5.56
4.5
3.7
0.00
0.01
estimate
0.50
55
270
20
62
3.36
5.54
1.2
1.3
260.67
308.42
ug/g
—
9
36
43
203
2.28
5.41
12.3
9.0
24.44
24.23
mmol/l
0.15
43
198
19
58
3.41
5.39
1.5
1.3
—
—
—
0
0
19
58
3.41
5.39
1.5
1.3
—
—
—
0
0
29
114
2.68
5.37
2.4
1.4
—
—
—
0
0
10
12
8.54
5.09
5.7
1.4
—
—
—
0
0
9
10
9.20
4.81
3.9
1.5
26.98
5.01
nmol/l
—
9
10
161
1215
1.61
4.48
2.4
2.4
79.47
76.97
nmol/l
0.50
149
1061
14
34
4.25
4.26
1.3
1.9
27.20
24.88
u/ml
—
5
8
149
1129
1.56
3.94
4.3
3.8
0.00
0.01
estimate
0.50
56
243
293
2605
1.80
3.88
49.3
15.3
73.80
73.97
ml/min/173m2
0.05
284
2413
41
218
2.00
3.83
3.0
2.6
56.50
59.21
ml/min/173m2
0.17
12
87
121
879
1.58
3.82
6.0
2.8
41.77
39.06
u/l
0.13
115
824
15
50
3.09
3.73
1.2
1.3
—
—
—
0
0
8
12
6.79
3.69
3.6
5.2
—
—
—
0
0
11
25
4.51
3.65
1.3
1.2
—
—
—
0
0
18
68
2.74
3.62
1.1
1.7
—
—
—
0
0
15
51
3.03
3.62
1.0
1.1
—
2.03
—
0
6
7
9
7.91
3.57
1.0
1.0
632.14
2195.67
miu/ml
—
7
9
166
1313
1.51
3.48
4.7
4.3
31.16
49.56
ng/l
1.88
151
1032
46
264
1.86
3.45
1.5
1.4
—
—
—
0
0
19
76
2.59
3.44
1.4
1.5
0.04
0.20
iu/ml
—
7
15
11
27
4.17
3.42
1.3
1.5
91.07
88.66
%
0.75
11
27
11
27
4.17
3.42
1.0
1.1
—
16.21
—
0
9
87
1197
0.64
3.30
2.4
2.0
1.39
1.32
mmol/l
0.40
69
968
12
35
3.51
3.13
2.6
4.3
—
—
—
0
0
17
68
2.58
3.09
1.4
1.6
—
—
—
0
0
8
16
5.09
3.07
1.7
1.3
—
—
—
0
0
106
784
1.51
2.98
4.3
3.2
0.04
0.00
estimate
0.49
52
230
37
208
1.87
2.97
6.2
2.5
1.29
1.17
%
0.30
37
208
20
89
2.32
2.93
2.4
2.2
116.00
134.38
g/l
3.83
20
71
36
202
1.87
2.90
4.4
2.5
0.61
0.62
%
0.07
36
202
13
47
2.83
2.85
1.8
3.0
9.03
11.49
pmol/l
0.41
13
47
41
246
1.76
2.68
4.2
2.9
113.80
131.89
g/l
4.15
41
241
43
263
1.72
2.63
2.9
2.3
0.18
0.36
e6/l
1.29
43
248
201
1717
1.41
2.49
4.0
3.4
61.58
53.72
u/l
0.59
191
1584
127
1006
1.41
2.42
2.0
1.7
18.03
20.00
nmol/l
0.91
116
840
8
22
3.70
2.38
3.1
1.5
4796.85
2.64
u/ml
—
8
22
32
187
1.78
2.30
4.6
2.9
24.90
25.16
mmol/l
0.19
32
182
22
116
1.96
2.16
1.6
2.9
4.17
4.41
pmol/l
0.52
22
100
19
96
2.04
2.09
1.0
1.1
—
—
—
0
0
9
31
2.95
2.08
1.4
1.8
—
314.00
—
0
5
5
10
5.05
2.07
1.0
1.2
—
—
—
0
0
20
106
1.94
1.95
1.1
1.2
78.35
86.25
u/ml
—
6
36
5
11
4.59
1.95
16.0
3.2
4.82
5.74
kpa
—
5
11
5
11
4.59
1.95
16.0
3.2
9.88
10.43
kpa
—
5
11
245
2660
0.73
1.85
6.1
7.5
40.14
40.63
mmol/mol
0.40
224
2456
222
1983
1.33
1.78
3.8
3.6
14.92
15.03
pmol/l
0.25
204
1767
8
31
2.62
1.67
4.5
1.6
14.82
44.31
u/ml
—
8
31
309
2923
1.52
1.66
74.4
23.5
190.63
233.92
e9/l
23.14
304
2844
309
2924
1.52
1.65
74.3
23.5
4.01
4.49
e12/l
35.98
302
2826
5
14
3.61
1.62
4.4
2.7
0.80
1.00
index
—
5
14
101
1213
0.76
1.48
3.1
3.4
6.34
8.02
mmol/l
5.94
85
1022
6
22
2.76
1.44
1.0
1.0
—
—
—
0
0
103
1227
0.77
1.40
3.8
4.2
35.55
8.26
mg/mmol
0.58
58
804
7
150
0.46
1.34
1.6
2.3
413.14
700.87
ug/l
—
7
140
250
2671
0.77
1.34
4.5
5.6
1.30
1.39
mmol/l
2.95
219
2430
5
18
2.80
1.29
1.0
1.3
150.80
94.61
pmol/l
—
5
18
5
18
2.80
1.29
1.0
1.0
—
—
—
0
0
68
538
1.33
1.25
1.2
1.3
0.68
1.39
u/ml
2.03
17
146
168
1495
1.24
1.19
2.2
2.2
90.59
94.64
pmol/l
0.68
100
790
8
38
2.13
1.19
1.5
1.4
—
—
—
0
0
260
2751
0.78
1.17
5.3
6.6
2.63
2.51
mmol/l
1.36
226
2515
254
2693
0.79
1.14
4.7
5.7
4.43
4.35
mmol/l
0.59
229
2473
18
111
1.66
1.14
1.1
1.2
—
—
u/ml
—
0
0
30
210
1.47
1.13
5.4
3.7
51.09
48.50
%
0.24
30
205
8
41
1.97
1.09
1.4
1.5
—
—
—
0
0
76
630
1.26
1.00
1.8
1.8
1373.93
1146.54
nmol/l
1.00
60
486
12
74
1.64
0.79
4.3
3.3
3.43
1.37
index
—
7
38
13
82
1.61
0.79
1.6
1.7
—
—
—
0
0
7
39
1.81
0.73
1.7
1.8
0.04
1.12
mmol/l
—
7
39
11
68
1.64
0.72
1.3
1.2
—
—
—
0
0
7
43
1.64
0.67
2.6
2.6
10.57
11.02
mmol/l
—
7
43
82
717
1.19
0.66
1.7
1.8
475.70
20172825.31
pmol/l
0.50
67
580
45
373
1.24
0.62
11.1
7.6
—
—
—
0
0
8
51
1.58
0.61
5.5
2.4
1.19
1.19
mmol/l
—
8
51
0
22
0.00
0.59
0.0
1.2
—
—
—
0
0
8
53
1.52
0.59
5.5
2.3
105.13
105.49
mmol/l
—
8
53
29
230
1.28
0.57
4.1
4.4
102.36
101.51
ng/l
0.01
22
198
6
38
1.59
0.54
5.8
1.8
1983.50
1230.84
mg
—
6
38
247
2566
0.87
0.53
4.1
4.8
1.35
1.27
mmol/l
0.74
217
2313
13
93
1.41
0.49
1.6
1.8
—
—
—
0
0
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
8
59
1.36
0.41
1.0
1.2
—
496.67
—
0
6
8
113
0.70
0.38
2.5
2.2
32.13
42.96
nmol/l
—
8
105
132
1391
0.92
0.31
5.2
4.1
21.99
24.24
%
1.20
75
686
255
2489
1.09
0.28
4.8
4.7
2.22
2.01
mu/l
1.30
236
2228
38
422
0.89
0.25
1.3
1.3
19.95
11.50
u/ml
0.18
16
142
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
0
10
0.00
0.21
0.0
6.8
—
5.86
—
0
10
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
0
12
0.00
0.21
0.0
1.2
—
166.83
—
0
12
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
0
13
0.00
0.21
0.0
4.3
—
—
—
0
0
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
20
227
0.87
0.18
1.5
1.5
—
—
—
0
0
7
60
1.17
0.18
2.0
1.4
—
—
—
0
0
101
974
1.05
0.14
3.6
2.9
0.79
0.74
ug/l
0.24
71
663
43
456
0.93
0.12
1.3
1.3
30.76
31.47
iu/ml
0.02
12
132
169
1721
0.96
0.10
5.8
4.4
3.47
2.04
ug/l
0.55
153
1536
71
686
1.04
0.09
4.7
4.1
1.02
1.02
kg/l
0.63
49
457
269
2694
0.99
0.00
5.4
5.7
5.97
6.17
mmol/l
2.21
243
2419
15
146
1.03
0.00
1.9
1.4
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.5
—
9.67
—
0
6
0
9
0.00
-0.00
0.0
7.2
—
10.73
—
0
9
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
7.77
—
0
5
0
7
0.00
-0.00
0.0
1.1
—
0.34
—
0
7
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
2.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
9
89
1.01
-0.00
1.2
1.2
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_MANTLE_CELL_LYMPHOMA – Mantle cell lymphoma
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).